The clinical symptoms of Parkinson's disease.

Sveinbjornsdottir, Sigurlaug·2016·Journal of Neurochemistry

Cited by (1,402)

Items 801–900 of 1,402

  1. Perceived social support in the daily life of people with Parkinson’s disease: a distinct role and potential classifier
    Júlia Schönfeldová, Chen Cohen, Ortal Otmazgin, William Saban · 2025 · Scientific Reports
  2. Ex PPN ing how acetylcholine improves gait in Parkinson's disease
    Björn H. Falkenburger · 2017 · Journal of Neurochemistry
  3. Oligodendrocytes: Morphology, functions and involvement in neurodegenerative diseases
    Izabela Krawczyk-Marć, Agata Wawrzyniak, Iwona Łuszczewska‐Sierakowska, Marek Babicz, Stanisław Orkisz · 2019 · Medycyna Weterynaryjna
  4. Biofluid Markers of Equine Neurological Disorders Reviewed From Human Perspectives
    Abubakar Musa Mayaki, Intan Shameha Abdul Razak, Noraniza Mohd Adzahan, Mazlan Mazlina, Rasedee Abdullah · 2019 · Journal of Equine Veterinary Science
  5. Critical review of verse “Evama Yeva Pittadhara Saeva Majjadharaiti”
    Pankaj S Musale, Desai Priti · 2020 · International Journal of Ayurvedic Medicine
  6. Cross-Sectional Design: Link Between Parkinson’s Pain and Restless Leg Syndrome
    Dion A. Paul, Abdul Rehman Qureshi, Muhammad Khizar Jamal · 2021 · Journal of Geriatric Psychiatry and Neurology
  7. Analysis of Impulse Control Disorders (ICDs) and Factors Associated with Their Development in a Parkinson’s Disease Population
    Mauricio Iván García-Rubio, María Elisa Otero Cerdeira, Christian Gabriel Toledo-Lozano, Sofía Lizeth Alcaráz‐Estrada, Juan Antonio Suárez‐Cuenca, Ramón Mauricio Coral‐Vázquez, Paul Mondragón‐Terán, Juan Antonio Pineda-Juárez, Luis Fernando Díaz-López, Silvia Garcı́a · 2021 · Healthcare
  8. Kinematic Relations during Double Support Phase in Parkinsonian Gait
    Ondřej Sitek, Miriam Kalichová, Petr Hedbávný, Tomáš Boušek, Marek Baláž · 2022 · Applied Sciences
  9. Clinical efficacy of probiotics in the treatment of constipation in Parkinson's patients
    Ting Yan, Jinzi SHI, Xiang Li · 2022 · Minerva Gastroenterology
  10. Levodopa treatment patterns in Parkinson’s disease: A retrospective chart review
    Prakash Navaratnam, Steve Arcona, Howard Steven Friedman · 2022 · Clinical Parkinsonism & Related Disorders
  11. Classification of Parkinson's Disease Patients and Effectiveness of Medication for Freezing of Gait
    Omid Mohamad Beigi, Lígia Reis Nóbrega, Sheridan K. Houghten, Adriano de Oliveira Andrade, Adriano Alves Pereira · 2022 · IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB)
  12. EEG Evaluation in a Neuropsychological Intervention Program Based on Virtual Reality in Adults with Parkinson’s Disease
    Daniela Muñoz, Patricio Barría, Carlos A. Cifuentes · 2022 · Biosensors
  13. Effect of home-based exercise programs with e-devices on falls among community-dwelling older adults: a meta-analysis
    Yuting Cao, Jianjie Wang, Yiting Yang, Shijie Zhu, Liang-dong Zheng, Weiwei Lu, Rui Zhu, Tao Wu · 2022 · Journal of Comparative Effectiveness Research
  14. Dysphonia-based Parkinson's Detection using Deep Learning and Ensemble Techniques
    Sai Akhil Varma Vegesna, Sai Teja Ginnegolla, Rithvik Reddy Yeruva, Vamsi Reddy Arimanda, Sindhuja Boda · 2023 · International Conference on Advanced Computing and Communication Systems (ICACCS)
  15. Ampreloxetine Versus Droxidopa in Neurogenic Orthostatic Hypotension: A Comparative Review
    Pranvera Hoxhaj, Shruti Shah, Veronica E Muyolema Arce, Wajiha Khan, Amirali Sadeghzadegan, Saumya Singh, Gaudy F Collado, Abhishek Goyal, Imran Khawaja, Deepti Botlaguduru et al. · 2023 · Cureus
  16. Testing the Validity of a Spatiotemporal Gait Model Using Inertial Measurement Units in Early Parkinson’s Patients
    Shuai Tao, Haoye Wang, Liwen Kong · 2023 · IEEE Access
  17. Role of Functional Neuroimaging with 123I-MIBG and 123I-FP-CIT in De Novo Parkinson’s Disease: A Multicenter Study
    Maria Silvia De Feo, Viviana Frantellizzi, Nicoletta Locuratolo, Arianna Di Rocco, Alessio Farcomeni, Caterina Pauletti, Andrea Marongiu, Julia Lazri, Susanna Maria Francesca Nuvoli, Francesco Fattapposta et al. · 2023 · Life
  18. A Review on Probiotic and Microbiota Modulation: A Promising Nutraceutical in the Management of Neurodegenerative and Psychiatric Conditions
    Anmol Kanda, Avijit Mazumder, Saumya Das, Vishnu Prabhakar · 2023 · Journal of Natural Remedies
  19. A Survey on AI-based Parkinson Disease Detection: Taxonomy, Case Study, and Research Challenges
    Shivani Desai, Kaju Patel, Anurag Patel · 2024 · Scalable Computing Practice and Experience
  20. Real-time visual verification of leap motion controller measurements for reliable finger tapping test in Parkinson’s disease
    Slavomír Kajan, Jozef Goga, Peter Matejička · 2024 · Journal of Electrical Engineering
  21. Disruption of the Brain Resting State Networks in Parkinsonism
    Mahdieh Ghasemi, Ali Foroutannia · 2019 · The Neuroscience Journal of Shefaye Khatam
  22. Nutrient‐sensing amyloid metastasis
    Luís Maurício T. R. Lima, Tháyna Sisnande · 2022 · BioFactors
  23. Phonological i-Vectors to Detect Parkinson’s Disease
    Nicanor García-Ospina, Tomás Arias‐Vergara, Juan Camilo Vásquez-Correa, Juan Rafael Orozco‐Arroyave, Miloš Cerňak, Elmar Nöth · 2018 · Lecture notes in computer science
  24. The state of Vitamin D in Iraqi Patients With Parkinson Disease
    Aqeel Kareem Hatem · 2019 · AL-Kindy College Medical Journal
  25. Análise de desvios posturais em indivíduos com Doença de Parkinson avaliados pela fotogrametria
    Rita de Cassia Niz Malko, Marina Wolff Branco, Adriano Zanardi da Silva · 2020 · Revista Neurociências
  26. Epidemiology of Parkinson's disease
    Tereza Bartoníková, Kateřina Menšíková, Vladimí­r Janout, Petr Kaňovský · 2020 · Neurologie pro praxi
  27. Validation of Differentially Expressed Brain-Enriched microRNAs in the Plasma of Parkinson’s Disease Patients
    Stylianos Ravanidis, Anastasia M. Bougea, Nikolaos Papagiannakis, Christos Koros, Athina‐Maria Simitsi, Ioanna Pachi, Marianthi Breza, Leonidas Stefanis, Epaminondas Doxakis · 2020
  28. Clinical and genetic insights of Parkinson’s Disease in a Mexican cohort: highlighting Latino’s diversity
    Alejandra Lázaro‐Figueroa, Paula Reyes‐Pérez, Eugenia Morelos-Figaredo, Carlos Manuel Guerra-Galicia, Ingrid E. Estrada-Bellmann, Karla Salinas-Barboza, Yamil Matuk-Pérez, Nadia Alejandra Gandarilla-Martínez, Dante Oropeza, Ulises Caballero-Sánchez et al. · 2023 · medRxiv
  29. MARTA: a model for the automatic phonemic grouping of the parkinsonian speech
    Alejandro Guerrero-López, Julián D. Arias-Londoño, Stefanie Shattuck‐Hufnagel, Juan Ignacio Godino-Llorente · 2024
  30. Research progress on microglial pyroptosis and inflammasomes: a comprehensive analysis
    Xiaofang Wang, Zhenyu Li, Bingxiang Ma, Qianfang Jia · 2025 · Frontiers in Aging Neuroscience
  31. Dingzhen pills inhibit neuronal ferroptosis and neuroinflammation by inhibiting the cGAS-STING pathway for Parkinson’s disease mice
    Gaoshuang Fu, Ting Li, Yukun Zhao · 2025 · Chinese Medicine
  32. Efficacy of Yijinjing-inspired exercises on sleep disorders in Parkinson’s disease: a controlled fNIRS study
    Zekai Hu, Jing Shi, Jinyan Wang, Ting Liu, Yujia Li, Han Xue, Xueming Jin, Yiting Xue, Jie Wang, Xinhao Liu et al. · 2025 · Frontiers in Psychiatry
  33. The role of motor subtypes in modulating neuropsychiatric and cognitive function in Parkinson's disease: A group-stratified mediation analysis
    Chia-Yi Chien, Chun‐Hsiang Tan, Wei‐Pin Hong, Kao Chin Chen, Rwei‐Ling Yu · 2025 · Journal of Psychiatric Research
  34. Harnessing the power of faecal microbiota transplantation: optimizing neuroimmune function for improved treatment of Parkinson's, Alzheimer's, and multiple sclerosis
    Souvik Roy, Debdeep Chattopadhyay, Lopamudra Choudhury, Subhrojyoti Ghosh, Atharva Anand Mahajan · 2025 · Discover Neuroscience
  35. A neuroprotective effect of newly isolated probiotic bacterium Lactobacillus acidophilus SLAM_LAA02 in a rotenone-induced mouse model of Parkinson’s disease
    Yeonsoo Kim, Eunsol Seo, Anna Kang, Min-Geun Kang, Ki Beom Jang, Sangnam Oh, Younghoon Kim · 2025 · Biomedicine & Pharmacotherapy
  36. Symptom-Specific Networks and the DBS-Modulated Network in Parkinson’s Disease: A Connectivity-Based Review
    Ransheng Huang, Kailiang Wang, Yuqing Zhang, Guoguang Zhao · 2025 · Brain Sciences
  37. Impact of Parkinson's Disease on Caregiver Quality of Life in Japan
    Koichi Nagaki, Ryoko Nakagawa, Miwako Ishido, Yoko Yoshinaga, Jun Watanabe, Kanako Kurihara, Yuka Hayashi, Hiromu Ogura, Takayasu Mishima, Shinsuke Fujioka et al. · 2023 · Movement Disorders Clinical Practice
  38. Evaluation of Transcranial Direct Current Stimulation in Motor Function and Neural Rehabilitation
    Xiaoxia Yuan, Xiaoke Zhong, Chen Wang, Yuan Yang, Changhao Jiang · 2023 · Journal of Ect
  39. Investigating trial design variability in trials of disease-modifying therapies in Parkinson’s disease: a scoping review protocol
    Marie‐Louise Zeissler, Timothy Boey, Danny Chapman et al. · 2023 · BMJ Open
  40. J24335 exerts neuroprotective effects against 6-hydroxydopamine-induced lesions in PC12 cells and mice
    Zhijian Pan, Min Shao, Chen Zhao, Xuanjun Yang, Haitao Li, Guozhen Cui, Xiaonan Liang, Chao‐Wu Yu, Qingqing Ye, Gao Cheng et al. · 2024 · European Journal of Pharmaceutical Sciences
  41. Amyloid, Crohn’s disease, and Alzheimer’s disease - are they linked?
    Anna Duda-Madej, Jakub Stecko, Natalia Szymańska, Agnieszka Miętkiewicz, Marta Szandruk-Bender · 2024 · Frontiers in Cellular and Infection Microbiology
  42. Depression is associated with the nonmotor symptoms of Parkinson's disease: A comparative analysis
    Mahsa Mayeli, Mahan Shafie, Maryam Shiravi, Tanin Adl Parvar, Zahra Mirsepassi, Fatemeh Rahiminejad, Reza Sattarpour, Vajiheh Aghamollaii · 2024 · Health Science Reports
  43. Exploring the cognitive implications of traditional and novel subthalamic nucleus deep brain stimulation paradigms in Parkinson’s disease
    Anouk Wolters, Yasin Temel, Hans Clusmann, Sarah Hescham · 2024 · Deep Brain Stimulation
  44. A novel super-resolution microscopy platform for cutaneous alpha-synuclein detection in Parkinson’s disease
    Ofir Sade, Daphna Fischel, Noa Barak-Broner, Shir Halevi, Irit Gottfried, Dana Bar-On, Stefan Sachs, Anat Mirelman, Avner Thaler, Aviv Gour et al. · 2024 · Frontiers in Molecular Neuroscience
  45. A systematic review of the factors associated with the psychological wellbeing of people with Parkinson’s in the COVID-19 pandemic
    H. Gotheridge, F. Eccles, C. Murray, R. Henderson, J. Simpson · 2024 · Disability and Rehabilitation
  46. Usability of a Mobile Application for Patients with Parkinson’s Disease
    Gent Ymeri, Benjamin Maus, Myrthe Wassenburg, Carl Magnus Olsson, Per Svenningsson, Dario Salvi · 2024 · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
  47. Exploring therapeutic potential of Bacopa monnieri bioactive compounds against Alzheimer’s and Parkinson’s diseases
    Richa Shukla, Krishna Misra, Sangeeta Singh · 2025 · 3 Biotech
  48. Brain-computer interfaces in neurorehabilitation for central nervous system diseases: Applications in stroke, multiple sclerosis and Parkinson's disease
    Sara Knežević · 2025 · SANAMED
  49. The Effect of Probiotic Lactic Acid Bacteria on the Symptoms of Mental Disorders
    V. Novikova, K. Bondarenko, A. Sazonov, A. S. Rozanov · 2024 · Nanobiotechnology Reports
  50. Increased plasma GPNMB levels in patients with parkinson’s disease and cognitive impairment
    Xuelin Qi, Zonghan She, Xiaoxue Shi, Haoran Peng, L M Wang, Jianjun Ma, Xiaohuan Li, Keke Liang, Yongyan Fan, Yunfei Sun et al. · 2025 · Scientific Reports
  51. COMPARISON OF COMBINED EFFECTS OF PHYSICAL AND MENTAL PRACTICE WITH PHYSICAL PRACTICE ALONE ON FUNCTIONAL INDEPENDENCE IN PARKINSON (PD) PATIENTS
    11/12, Thube Park, Shivajinagar, Pune, Maharashtra, India., Marya Lokhandwala, Vivek Kulkarni, 11/12, Thube Park, Shivajinagar, Pune, Maharashtra, India., Manasa Nair, 11/12, Thube Park, Shivajinagar, Pune, Maharashtra, India. · 2019 · International Journal of Physiotherapy and Research
  52. Multidimensional Neo-Fuzzy-Neuron for Solving Medical Diagnostics Tasks in Online-Mode
    Samer Mohamed Kanaan Mahmoud, Iryna Perova, Iryna Pliss · 2020 · Wydawnictwo Politechniki Łódzkiej
  53. Excess activity of 3-hydroxykynurenine, quinolinic acid, and other toxic tryptophan metabolites in neurogenerative diseases and other protein misfolding diseases
    Peter P. Sordillo, Laura A. Sordillo · 2021 · Elsevier eBooks
  54. Narcolepsy in Parkinson's disease with insulin resistance
    Alisha Chunduri, Wim E. Crusio, Anna Delprato · 2022 · F1000Research
  55. Neurotoxin models and treatments of Parkinson’s disease
    Wasim Akram, Vishal Kumar, Swamita Arora · 2022 · International Journal of Health Sciences
  56. A Simple Yet Effective Hand Pose Tremor Classification Algorithm To Diagnosis Parkinsons Disease
    MingYa Zhang, Na Zhao, Yue Yu · 2022 · IEEE International Conference on Bioinformatics and Biomedicine (BIBM)
  57. Effectiveness of deep brain stimulation in Parkinson’s disease treatment with Single-center experience in Pakistan
    Aurangzeb Kalhoro, Abdul Sattar M. Hashim · 2023 · Pakistan Journal of Medical Sciences
  58. Tracking social behaviour with smartphones in people with Parkinson's: a longitudinal study
    Heng Zhang, Bijan Parsia, Ellen Poliakoff, Simon Harper · 2023 · Behaviour and Information Technology
  59. Differences and Changes in Cerebellar Functional Connectivity of Parkinson’s Patients with Visual Hallucinations
    Liangcheng Qu, Chuan Liu, Yiting Cao, Kuiying Yin, Weiguo Liu, Jingping Shi · 2023 · Brain Sciences
  60. The Golgi complex of dopaminergic enteric neurons is fragmented in a hemiparkinsonian rat model
    Mireia Cara‐Esteban, Maria Pilar Marín, Emma Martínez‐Alonso, Sergio Martínez‐Bellver, Vicent Teruel‐Martí, José A. Martínez‐Menárguez, Mónica Tomás · 2023 · Microscopy Research and Technique
  61. Two Cases of Korean Medicine Treatment for Patients with Parkinson’s Disease Evaluated Using a Three-Dimensional Gait Analysis System
    Hye-Jin Lee, Ye-chae Hwang, Kyeong-hwa Lee, Dong-joo Kim, Seung‐Yeon Cho, Jung‐Mi Park, Chang‐Nam Ko, Seong-Uk Park · 2023 · The Journal of Internal Korean Medicine
  62. Yin Yang 1 suppresses apoptosis and oxidative stress injury in SH-SY5Y cells by facilitating NR4A1 expression
    Qin Kang, Wen Chai, Jun Min, Xin-Hui Qu · 2023 · Journal of Neurogenetics
  63. Unravelling the Parkinson’s puzzle, from medications and surgery to stem cells and genes: a comprehensive review of current and future management strategies
    Krishnapriya Chandrababu, Vineeth Radhakrishnan, A S Anjana, Rahul S. Rajan, Unnikrishnan Sivan, Syam Krishnan, P. S. Baby Chakrapani · 2023 · Experimental Brain Research
  64. Beneficial effect of 5‐HT1b/1d agonist on Parkinson's disease by modulating glutamate and reducing deposition of α‐synuclein
    Alok Shiomurti Tripathi, Needa Fatima, Pankaj Tripathi, Rina Tripathi, Alka, Magdi E. A. Zaki, Lucy Mohapatra, Mohammad Yasir, Rahul Kumar Maurya · 2023 · Journal of Biochemical and Molecular Toxicology
  65. The relationship between obstructive sleep apnea and visual hallucinations in PD patients: a polysomnography study
    Jun Zhu, Yang Zhao, Yinyin Jiang · 2024 · Frontiers in Neurology
  66. Neuroprotection induced by terpenes: focus on Alzheimer’s disease and Parkinson’s disease
    Manal Lahyaoui, Abdelhakim Bouyahya, Naoual El Menyiy, Saad Bakrim, Nadia Dakka · 2024 · Elsevier eBooks
  67. What are the effects of aquatic physiotherapy exercises on speed and complex gait-related activities in individuals with Parkinson's disease?
    Tainá Christinelli, Dielise Debona Iucksch, Juliana Siega · 2024 · Journal of Bodywork and Movement Therapies
  68. Lexical Retrieval Performance in Patients with Normal Pressure Hydrocephalus and Parkinson’s Disease
    So-Hee Kim, Ki‐Su Park, Kyunghun Kang · 2024 · Eon'eo cheong'gag jang'ae yeon'gu/Communication sciences & disorders
  69. Psychometric properties of 3-meter backward walk test (3MBWT) in people with Parkinson disease
    Kristen Barta, Anne H Boddy, Megan Flores · 2024 · Physiotherapy Theory and Practice
  70. The effects of laser cane cues on the freezing of gait of Parkinson’s disease patients: can increasing the laser light beam width play a role?
    Mehri Salari, Ronak Rashedi, Feryal Momenilandi, Mehdi Bostan Shirin, Masoud Etemadifar · 2024 · Acta Neurologica Belgica
  71. Non-smooth optimization algorithm to solve the LINEX soft support vector machine
    Soufiane Lyaqini, Aissam Hadri, Lekbir Afraites · 2024 · ISA Transactions
  72. A deep learning approach for classification of Parkinson’s disease using single photon emission computerized tomography
    Reema Ganotra, Shailender Gupta · 2025 · Multimedia Tools and Applications
  73. Machine learning-based brain magnetic resonance imaging radiomics for identifying rapid eye movement sleep behavior disorder in Parkinson’s disease patients
    Yandong lian, Yibin Xu, Linlin Hu · 2025 · BMC Medical Imaging
  74. Pre- and Post- COVID-19 Pandemic Pneumonia Rates in Hospitalized Schizophrenia Patients
    Ana Aliana Miron, Petru Iulian Ifteni, Alexandra-Elena Lungu, E Dragomirescu, Lorena Dima, Andreea Teodorescu · 2025 · Medicina
  75. An IoT-Based Framework for Health Monitoring Systems
    N. Sudhakar Yadav, Krishnarajanagar G. Srinivasa, B. Eswara Reddy · 2018 · International Journal of Fog Computing
  76. Neurodegenerative Diseases and Their Therapeutic Approaches
    Farhin Patel, Palash Mandal · 2019 · IntechOpen eBooks
  77. A Machine-Learning Based Emotion Recognition System in Patients with Parkinson’s Disease
    Marianna Capecci, Lucio Ciabattoni, Gabriele Foresi, Andrea Monteriù, Lucia Pepa · 2019 · International Conference on Consumer Electronics
  78. Of worms and men
    John Graham White · 2020 · Journal of Neurogenetics
  79. Tablet-based patient educational interventions in care and management of complex movement disorders
    Natalie Hellmers, Samantha Barkan, Gabrielle Auerbach, Aneliya Hanineva, Paul Popa, Harini Sarva, Claire Henchcliffe · 2021 · Disability and Rehabilitation Assistive Technology
  80. Synthesis of Proposed Structure of Aaptoline B via Transition Metal-Catalyzed Cycloisomerization and Evaluation of Its Neuroprotective Properties in C. Elegans
    Soobin Kim, Wooin Yang, Dong-Seok Han · 2021 · Applied Sciences
  81. Low protein diet: Its relevance to Manganese-induced neurotoxicity in rats treated with Coenzyme Q10 and/or Epigallocatechin-3-gallate.
    Amany S. Aboutaleb, Hebatalla I. Ahmed, Mona M. Kamal, Azza A. Ali · 2021 · Azhar International Journal of Pharmaceutical and Medical Sciences/Azhar International Journal of Pharmaceutical and Medical Sciences
  82. Parkinson's disease
    Juan Segura‐Aguilar · 2021 · Elsevier eBooks
  83. Time Perception of an Artwork’s Manipulation Is Distorted by Patients With Parkinson’s Disease
    Márcia Regina Motta, Vítor Tumas, José Lino Oliveira Bueno · 2019 · Frontiers in Integrative Neuroscience
  84. Neuroprotective Treatments in Parkinson’s Disease
    Elif Çınar, Gül Yalçın Çakmaklı, Banu Cahide Tel · 2019 · Turkish Journal Of Neurology
  85. Roles of Cannabidiol in Reversing Proteinopathies
    Raju Dash, Md. Chayan Ali, Israt Jahan, Yeasmin Akter Munni, Sarmistha Mitra, Md. Abdul Hannan, Binod Timalsina, Diyah Fatimah Oktaviani, Ho Jin Choi, Il Soo Moon · 2020 · Preprints.org
  86. Glycation modulates glutamatergic signalling and exacerbates Parkinson’s disease-like phenotypes
    Ana Chegão, Mariana Guarda, Bruno M. Alexandre, Liana Shvachiy, Mariana Temido‐Ferreira, Inês Marques-Morgado, Bárbara Fernandes Gomes, Rune Matthiesen, Luísa Vaqueiro Lopes, Pedro R. Florindo et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  87. COMPUTATIONAL ANALYSIS OF PHYTOCOMPOUNDS PRESENT IN LEUCAS ASPERA TO TARGET PARKINSON’S DISEASE-CAUSING ALPHA-SYNUCLEIN
    ASHTON MENEZES · 2022 · Innovare Journal of Medical Sciences
  88. Review article: the role of epigenetics as an underlying regulator of the immune responses in Parkinson’s disease
    Maria Georgoula, Panagiotis Ntavaroukas, Barry James Campbell, Stamatia Papoutsopoulou · 2024 · Epigenetics Reports
  89. Parkin mediates the mitochondrial dysfunction through mRpL18
    Xiuxiu Ti, Hui Zuo, Guochun Zhao, Yuwei Li, Minghui Du, Liwen Xu, Shengnan Li, Zhaoliang Shan, Yuxue Gao, Guangming Gan et al. · 2025 · Journal of Biological Chemistry
  90. Investigating Balance Perception and Balance Performance in Neurological Disorders for Targeted Rehabilitation Strategies
    Rebecca Cardini, Alessandro Torchio, Irene Giovanna Aprile, Andrea Turolla, Davide Cattaneo, Elisa Gervasoni · 2025 · Physical Therapy
  91. Human-centred design process when users have an evolving profile: a case study in Parkinson's disease domain
    Káthia Marçal de Oliveira, Christophe Kolski, Sophie Lepreux et al. · 2025 · Proceedings of the ACM on Human-Computer Interaction
  92. A novel stable transgenic zebrafish line expressing mCherry-tagged human alpha-synuclein in the nervous system and exhibiting all the key features of Lewy body disorders at larval stage
    Silvia Zini, Alessia Muscò, Francesca Longhena, Gaia Faustini, Chiara Tobia, Giuseppe Borsani, Maria Grazia Spillantini, Daniela Zizioli, Arianna Bellucci · 2025 · Neurobiology of Disease
  93. Excessive Daytime Sleepiness in Parkinson’s Disease and Parkinsonism
    Iulia Murășan, Ștefania Diaconu, Anastasia M. Bougea, Cristian Falup‐Pecurariu · 2025 · Sleep Medicine Clinics
  94. VIM thalamotomy with MRgFUS in Parkinson's disease: Efficacy, safety and technique
    Raisa Braña Miranda, Francisco Rivera, Nelson Ernesto Quintanal Cordero · 2025 · NeuroTarget
  95. Magnetic resonance-guided focused ultrasound pallidotomy in Parkinson's disease: a systematic review of efficacy and safety
    Francisco Rivera, Nelson Ernesto Quintanal Cordero, Raisa Braña Miranda · 2024 · NeuroTarget
  96. Neural networks reveal novel gene signatures in Parkinson disease from single-nuclei transcriptomes
    Michael R. Fiorini, Jialun Li, Edward A. Fon, Sali M.K. Farhan, Rhalena A. Thomas · 2025 · npj Parkinson s Disease
  97. Synergy between stem cell therapy and brain-derived neurotrophic factor (BDNF) in Parkinson’s disease: a mini-review of combined neuroregenerative strategies
    Jonny Jonny, Astrid Devina Larasati, Queenesa Amabel Sunjaya, Ahmad Faried · 2025 · Chinese Neurosurgical Journal
  98. Calcium-based synaptic and structural plasticity link pathological activity to synaptic reorganization in Parkinson’s disease
    Cathal McLoughlin, Justus A. Kromer, Madeleine M. Lowery · 2025 · Science Advances
  99. Assessment of [125I]a-Bungarotoxin Binding to a7 Nicotinic Acetylcholinergic Receptors in Hippocampus-Subiculum of Postmortem Human Parkinson’s Disease Brain
    Fariha Karim, Allyson Ngo, Titus E. Tucker, Ashlee D. L. Coronel, Jogeshwar Mukherjee · 2025 · Biomolecules
  100. Molecular mechanism analysis and network pharmacology of capsaicin in Alzheimer’s and Parkinson’s diseases: an in silico study
    Luis Antonio Ramirez Contreras, Luis Miguel Anaya-Esparza, Salvador Hernández Estrada, Luis Alfonso Hernández-Villaseñor, Jorge Manuel Silva Jara, Leonardo Hernández, Gabriela Camargo-Hernández, Andrés Frausto de Alba · 2025 · Exploration of Neuroprotective Therapy